Switching from semaglutide to tirzepatide without losing the floor

A reader who'd been on semaglutide 1mg for fourteen months wrote in last week. Plateau at month nine. Side effects manageable. Wanted to switch to tirzepatide for the GIP receptor pull. Asked the question I get a lot: do I start tirzepatide at 2.5mg like everyone else, or do I jump higher because I'm already adapted to a GLP-1?

The honest answer is somewhere in the middle, and the reasoning matters more than the dose number.

What the receptor math actually says

Semaglutide is a GLP-1 mono-agonist. Tirzepatide is a GLP-1 + GIP dual agonist. They're not the same drug at different strengths. The GIP arm of tirzepatide is doing different work in your gut and your hypothalamus, and your body has not been exposed to it.

If you've been on semaglutide 1mg for a year, your GLP-1 receptor side is well-trained. The nausea you'd get on a treatment-naive 2.5mg tirzepatide start is largely a GLP-1 effect, and you've already adapted to most of it. The new variable is the GIP signal, which most people tolerate cleanly but a small minority do not. You don't know which one you are until you find out.

The clinically conservative move: start tirzepatide at 2.5mg for two weeks even if you've been on semaglutide for a year. This is what most US prescribers will give you regardless. The semaglutide adaptation buys you a smoother ramp on the GLP-1 side, and the 2.5mg starter exposes you to GIP at a dose where the worst case is "uncomfortable for a week."

The aggressive move some endocrinologists allow: skip the 2.5mg phase and start at 5mg. Justifiable if you tolerated semaglutide 1mg cleanly for six months or more. Not what most clinics will write. If you ask for it, expect to be told no.

The washout question

Here's where most reader emails go wrong. People assume they need a long washout between drugs. They don't.

Semaglutide's half-life is about a week. Tirzepatide's is similar. If you injected your last semaglutide dose on a Sunday and started tirzepatide the following Sunday, you'd have meaningful semaglutide concentration overlap for another two weeks. That's fine. Both drugs activate the GLP-1 receptor; doubling up isn't dangerous at your established dose, and you avoid the rebound spike in appetite that a long washout produces.

The actual protocol most clinics use: skip one weekly semaglutide dose, then start tirzepatide on the day you would have injected. No washout. The semaglutide tail covers the first week of tirzepatide ramp.

The exception is if you stopped semaglutide for an unrelated reason, like a side effect or supply gap, and you're four weeks past the last dose. Then you've already had the rebound and starting tirzepatide is a fresh start. Begin at 2.5mg and ramp normally.

What to watch in the first month

The two weight patterns I've seen on switches:

The body recalibrates in week three or four and the scale picks back up to where it was tracking on semaglutide. Then the GIP pull kicks in around week six or eight and progress accelerates. This is the most common pattern.

The scale moves up two or three pounds in the first ten days. People panic. The drugs cleared overlap, the GIP signal hasn't fully engaged yet, and there's a brief window where appetite suppression is lower than baseline. It corrects within two weeks. Don't change anything.

If the scale is still moving the wrong way at four weeks past the switch and you've been on tirzepatide 2.5mg the whole time, that's the moment to step up to 5mg. Not before.

The dose ceiling question

Most people who switch from semaglutide 1mg to tirzepatide land around tirzepatide 7.5mg as their long-term effective dose. Some need 10mg. A few do well at 5mg. Almost none need 15mg, and the people who do are usually pushing past where their body wants to go.

If you were a partial responder to semaglutide (lost 5% over twelve months and stalled), tirzepatide will likely give you another 5-10% on top, but it won't make you a complete responder if you weren't one. The biology is correlated. Set the expectation now.

The thing I'd say if you asked me

Switch when the plateau on semaglutide is sustained for three months at the same dose, not when you hit a single bad week. Take the conservative ramp. Trust the four-week recalibration. The GIP arm is real but it's not magic, and people who go in expecting magic end up disappointed at month two when they're tracking the same trajectory they were on semaglutide.

If you're switching for side effects rather than plateau, the conversation is different and worth a separate post.